Original document(12 pages)  中文版
    The present invention provides one kind of compound emulsion of docetaxel and volatile Chinese medicine oil for intravenous injection and its preparation process. Docetaxel is first dissolved in volatile Chinese medicine oil, and the obtained solution is then prepared into the compound emulsion together with emulsifier, osmotic regulator, tocophenol, pH regulator and water for injection. Compounding docetaxel with volatile Chinese medicine oil can reduce the untoward reaction, dissolve docetaxel, raise curative effect and raise the clinical medicine safety. The preparation process is simple and feasible and suitable for industrial production.
Application Number
申请号
200610116277 Application Date
申请日
2006.09.20
Title 名称 Compound emulsion of docetaxel and volatil Chinese medicine oil for intravenous injection and its prepn process
Publication Number
公开号
1931158 Publication Date
公开日
2007.03.21
Approval Pub. Date Granted Pub. Date
International Classification 分类号 A61K31/337;A61K9/107;A61K47/44;A61P35/00
Applicant(s) Name
申请人
Huang Chengan
Address 地址
Inventor(s) Name 发明人
Attorney & Agent 代理人 suncui fang
More information 更  多  信  息


 Related patents information
Novel paclitaxel emulsion for intravenous injection and its preparation method
Paclitaxel injection, and its prepn. method
Composite intravenous injection emulsion of paclitaxel and traditional medicine volatile oil and its preparation process
Preparation of paclitaxel, and its preparing method
Self-emulsifying capsule of docetaxel and its preparation method
Compound paclitaxel preparation containing phospholipid dispersant and its preparation method
Docetaxel injecta and preparing method
Google
Note:All patent data come from State Intellectual Property Office of the People's Republic of China. If there were discrepancies between here and the State Intellectual Property office, the later is more accurate. The patent data is only for public exchange and learning purposes. We are not responsible for the adverse consequences with unverified use of the data.